Literature DB >> 10470331

Early and late onset in idiopathic and alcoholic chronic pancreatitis. Different clinical courses.

P Layer1, E P DiMagno.   

Abstract

In summary, a prerequisite for the development of alcoholic pancreatitis would be the specific individual predisposition present in patients with late-onset idiopathic chronic pancreatitis. Furthermore, because the reported prevalence of chronic pancreatitis in patients with heavy alcohol consumption is markedly higher than the prevalence of late-onset idiopathic pancreatitis in the general population, the authors conclude that, in predisposed patients, alcohol consumption promotes the development of pancreatitis and accelerates the manifestation of symptoms and complications. This concept explains the observation that only a minority of severe alcoholics develop chronic pancreatitis. Conversely, in postmortem studies, a substantial proportion of older individuals without premortem evidence of pancreatic disease and no excessive alcohol history have pancreatic morphologic alterations resembling chronic pancreatitis. Thus, in the general population, a considerable number of asymptomatic "carriers," together with an undetected high prevalence of late-onset idiopathic chronic pancreatitis, may exist. In these persons, alcohol consumption might amplify and accelerate preexisting asymptomatic idiopathic pancreatic damage. As a consequence, in a dose-dependent manner, alcohol may lead to an earlier onset of or induce clinically apparent pancreatitis in persons who otherwise might never have had symptoms during their lives.

Entities:  

Mesh:

Year:  1999        PMID: 10470331     DOI: 10.1016/s0039-6109(05)70047-5

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  7 in total

1.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.

Authors:  Robert R McWilliams; Gloria M Petersen; Kari G Rabe; Leonard M Holtegaard; Pamela J Lynch; Michele D Bishop; W Edward Highsmith
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

2.  Risk of pancreatic adenocarcinoma in chronic pancreatitis.

Authors:  D Malka; P Hammel; F Maire; P Rufat; I Madeira; F Pessione; P Lévy; P Ruszniewski
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 3.  Endoscopic and Conservative Management of Chronic Pancreatitis and Its Complications.

Authors:  Alexander Waldthaler; Roberto Valente; Urban Arnelo; J-Matthias Löhr
Journal:  Visc Med       Date:  2019-04-03

4.  Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group.

Authors:  Ákos Szücs; Tamás Marjai; Andrea Szentesi; Nelli Farkas; Andrea Párniczky; György Nagy; Balázs Kui; Tamás Takács; László Czakó; Zoltán Szepes; Balázs Csaba Németh; Áron Vincze; Gabriella Pár; Imre Szabó; Patrícia Sarlós; Anita Illés; Szilárd Gódi; Ferenc Izbéki; Judit Gervain; Adrienn Halász; Gyula Farkas; László Leindler; Dezső Kelemen; Róbert Papp; Richárd Szmola; Márta Varga; József Hamvas; János Novák; Barnabás Bod; Miklós Sahin-Tóth; Péter Hegyi
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

5.  The different course of alcoholic and idiopathic chronic pancreatitis: A long-term study of 2,037 patients.

Authors:  Lu Hao; Li-Sheng Wang; Yu Liu; Teng Wang; Hong-Lei Guo; Jun Pan; Dan Wang; Ya-Wei Bi; Jun-Tao Ji; Lei Xin; Ting-Ting Du; Jin-Huan Lin; Di Zhang; Xiang-Peng Zeng; Wen-Bin Zou; Hui Chen; Ting Xie; Bai-Rong Li; Zhuan Liao; Zhi-Jie Cong; Zheng-Lei Xu; Zhao-Shen Li; Liang-Hao Hu
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

6.  A proposal for a new clinical classification of chronic pancreatitis.

Authors:  Markus W Büchler; Marc E Martignoni; Helmut Friess; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2009-12-14       Impact factor: 3.067

7.  Cingulate glutamate levels associate with pain in chronic pancreatitis patients.

Authors:  Tine Maria Hansen; Janusiya Anajan Muthulingam; Asbjørn Mohr Drewes; Søren Schou Olesen; Jens Brøndum Frøkjær
Journal:  Neuroimage Clin       Date:  2019-07-02       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.